Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects
Clinical trial NCT02106585 · COMPLETED
Trial details
- NCT number
- NCT02106585
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-08-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.